Immunogenicity and Safety of Sci-B-Vac® to Engerix-B® in Adults
Clinical trial NCT03393754 · COMPLETED
Trial details
- NCT number
- NCT03393754
- Sponsor
- VBI Vaccines Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-13
- Primary completion
- 2019-04-08
- Enrollment
- 1607
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.